Skip to main content
Figure 2 | Trials

Figure 2

From: The impact of dose of the angiotensin-receptor blocker valsartan on the post-myocardial infarction ventricular remodeling: study protocol for a randomized controlled trial

Figure 2

Titration scheme of study drug. In the usual dose group, valsartan 40 mg twice a day is administrated throughout the study period. For those in the high dose group, dose is up-titrated to 80 mg twice a day before hospital discharge and finally to 160 mg twice a day after 2 weeks during outpatient visits.

Back to article page

Trials

ISSN: 1745-6215